{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:01:11Z","timestamp":1792803671469,"version":"4.5.0"},"reference-count":70,"publisher":"MDPI AG","issue":"16","license":[{"start":{"date-parts":[[2024,8,21]],"date-time":"2024-08-21T00:00:00Z","timestamp":1724198400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Research Sector at Kuwait University","award":["MG02\/15"],"award-info":[{"award-number":["MG02\/15"]}],"id":[{"id":"https:\/\/ror.org\/021e5j056","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>In gastrointestinal stromal tumors (GISTs), identifying prototypical mutations in the KIT\/PDGFRA oncogenes, or in rare alternate genes, is essential for prognostication and predicting response to tyrosine kinase inhibitors. Conversely, wild-type GISTs (WT-GIST), which lack known mutations, have limited treatment options. Data on the mutational landscape of GISTs and their impact on disease progression are very limited in Kuwait. Using a targeted next-generation sequencing panel, we investigated the spectrum and frequency of KIT, PDGFRA, and RAS-pathway-related mutations in 95 out of 200 GISTs diagnosed at Kuwait Cancer Center from 2005 to 2023 and assessed their correlation with clinicopathological parameters. Among the 200 tumors (median age 55 years; 15\u201391), 54% originated in the stomach, 33% in the small bowel, 7% in the colorectum, 1.5% in the peritoneum, and 4.5% had an unknown primary site. Of the 95 molecularly profiled cases, 88% had a mutation: KIT (61%), PDGFRA (25%), NF1 (2%), and one NTRK1 rearrangement. Ten WT-GISTs were identified (stomach = 6, small bowel = 2, and colorectum = 2). WT-GISTs tended to be smaller (median 4.0\u2009cm; 0.5\u20138.0) (p = 0.018), with mitosis \u22645\/5 mm2, and were of lower risk (p = 0.019). KIT mutations were an adverse indicator of disease progression (p = 0.049), while wild-type status did not significantly impact progression (p = 0.934). The genetic landscape in this cohort mirrors that of global studies, but regional collaborations are needed to correlate outcomes with genetic variants.<\/jats:p>","DOI":"10.3390\/cancers16162907","type":"journal-article","created":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T04:26:57Z","timestamp":1724300817000},"page":"2907","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Molecular Profiling of KIT\/PDGFRA-Mutant and Wild-Type Gastrointestinal Stromal Tumors (GISTs) with Clinicopathological Correlation: An 18-Year Experience at a Tertiary Center in Kuwait"],"prefix":"10.3390","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5747-8900","authenticated-orcid":false,"given":"Rola H.","family":"Ali","sequence":"first","affiliation":[{"name":"Department of Pathology, College of Medicine, Kuwait University, Safat 13110, Kuwait"},{"name":"Histopathology Laboratory, Sabah Hospital, Sabah Medical District, Safat 13001, Kuwait"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad R.","family":"Alsaber","sequence":"additional","affiliation":[{"name":"Department of Management, College of Business and Economics, American University of Kuwait, Safat 13034, Kuwait"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asit K.","family":"Mohanty","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Kuwait Cancer Center, Sabah Medical District, Safat 13001, Kuwait"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulsalam","family":"Alnajjar","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Kuwait Cancer Center, Sabah Medical District, Safat 13001, Kuwait"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8470-7833","authenticated-orcid":false,"given":"Eiman M. A.","family":"Mohammed","sequence":"additional","affiliation":[{"name":"Molecular Genetics Laboratory, Kuwait Cancer Center, Sabah Medical District, Safat 13001, Kuwait"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"Alateeqi","sequence":"additional","affiliation":[{"name":"Molecular Genetics Laboratory, Kuwait Cancer Center, Sabah Medical District, Safat 13001, Kuwait"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-5778-1159","authenticated-orcid":false,"given":"Hiba","family":"Jama","sequence":"additional","affiliation":[{"name":"Molecular Genetics Laboratory, Kuwait Cancer Center, Sabah Medical District, Safat 13001, Kuwait"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3094-1891","authenticated-orcid":false,"given":"Ammar","family":"Almarzooq","sequence":"additional","affiliation":[{"name":"Molecular Genetics Laboratory, Kuwait Cancer Center, Sabah Medical District, Safat 13001, Kuwait"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noelle","family":"Benobaid","sequence":"additional","affiliation":[{"name":"Molecular Genetics Laboratory, Kuwait Cancer Center, Sabah Medical District, Safat 13001, Kuwait"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zainab","family":"Alqallaf","sequence":"additional","affiliation":[{"name":"Molecular Genetics Laboratory, Kuwait Cancer Center, Sabah Medical District, Safat 13001, Kuwait"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9276-7230","authenticated-orcid":false,"given":"Amir A.","family":"Ahmed","sequence":"additional","affiliation":[{"name":"Molecular Genetics Laboratory, Kuwait Cancer Center, Sabah Medical District, Safat 13001, Kuwait"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shakir","family":"Bahzad","sequence":"additional","affiliation":[{"name":"Molecular Genetics Laboratory, Kuwait Cancer Center, Sabah Medical District, Safat 13001, Kuwait"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Alkandari","sequence":"additional","affiliation":[{"name":"Histopathology Laboratory, Farwaniya Hospital, Sabah Al Nasser Area 92426, Kuwait"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,8,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/S0140-6736(07)60780-6","article-title":"Gastrointestinal stromal tumour","volume":"369","author":"Rubin","year":"2007","journal-title":"Lancet"},{"key":"ref_2","first-page":"1259","article-title":"Gastrointestinal pacemaker cell tumor (GIPACT): Gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal","volume":"152","author":"Kindblom","year":"1998","journal-title":"Am. J. Pathol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/S0140-6736(13)60106-3","article-title":"Gastrointestinal stromal tumour","volume":"382","author":"Joensuu","year":"2013","journal-title":"Lancet"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1097\/PAS.0b013e31822d63a7","article-title":"Natural history of imatinib-naive GISTs: A retrospective analysis of 929 cases with long-term follow-up and development of a survival nomogram based on mitotic index and size as continuous variables","volume":"35","author":"Rossi","year":"2011","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1002\/jso.23873","article-title":"Gastrointestinal stromal tumors (GISTs) at uncommon locations: A large population based analysis","volume":"111","author":"Kukar","year":"2015","journal-title":"J. Surg. Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/s41379-021-00949-w","article-title":"Gastrointestinal stromal tumors (GISTs) arising in uncommon locations: Clinicopathologic features and risk assessment of esophageal, colonic, and appendiceal GISTs","volume":"35","author":"Hu","year":"2022","journal-title":"Mod. Pathol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1097\/00000478-199909000-00015","article-title":"Gastrointestinal stromal tumors\/smooth muscle tumors (GISTs) primary in the omentum and mesentery: Clinicopathologic and immunohistochemical study of 26 cases","volume":"23","author":"Miettinen","year":"1999","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_8","unstructured":"WHO Classification of Tumours Editorial Board (2024, July 01). WHO Classification of Tumours Series: Soft Tissue and Bone Tumours, Available online: https:\/\/tumourclassification.iarc.who.int\/chapters\/33."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1365-2559.2008.02977.x","article-title":"Clinical significance of oncogenic KIT and PDGFRA mutations in gastrointestinal stromal tumours","volume":"53","author":"Lasota","year":"2008","journal-title":"Histopathology"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1097\/PAS.0000000000000418","article-title":"KIT, PDGFRA, and BRAF mutational spectrum impacts on the natural history of imatinib-naive localized GIST: A population-based study","volume":"39","author":"Rossi","year":"2015","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"3","DOI":"10.21037\/tgh.2018.01.01","article-title":"Neoadjuvant therapy for gastrointestinal stromal tumor","volume":"3","author":"Ishikawa","year":"2018","journal-title":"Transl. Gastroenterol. Hepatol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1126\/science.279.5350.577","article-title":"Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors","volume":"279","author":"Hirota","year":"1998","journal-title":"Science"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/S0016-5085(98)70079-4","article-title":"A novel gain-of-function mutation of c-kit gene in gastrointestinal stromal tumors","volume":"115","author":"Nakahara","year":"1998","journal-title":"Gastroenterology"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1126\/science.1079666","article-title":"PDGFRA activating mutations in gastrointestinal stromal tumors","volume":"299","author":"Heinrich","year":"2003","journal-title":"Science"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1001\/jamaoncol.2016.5751","article-title":"Effect of KIT and PDGFRA mutations on survival in patients with gastrointestinal stromal tumors treated with adjuvant imatinib: An exploratory analysis of a randomized clinical trial","volume":"3","author":"Joensuu","year":"2017","journal-title":"JAMA Oncol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"4342","DOI":"10.1200\/JCO.2003.04.190","article-title":"Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor","volume":"21","author":"Heinrich","year":"2003","journal-title":"J. Clin. Oncol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.ejca.2006.01.030","article-title":"KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumours","volume":"42","author":"Sciot","year":"2006","journal-title":"Eur. J. Cancer."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/S1470-2045(20)30269-2","article-title":"Avapritinib in advanced PDGFRA D842V-mutant gastrointestinal stromal tumour (NAVIGATOR): A multicentre, open-label, phase 1 trial","volume":"21","author":"Heinrich","year":"2020","journal-title":"Lancet Oncol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"4182","DOI":"10.1158\/1078-0432.CCR-04-2245","article-title":"Acquired resistance to imatinib in gastrointestinal stromal tumor occurs through secondary gene mutation","volume":"11","author":"Antonescu","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"5352","DOI":"10.1200\/JCO.2007.15.7461","article-title":"Primary and secondary kinase genotypes correlate with the biological and clinical activity of sunitinib in imatinib-resistant gastrointestinal stromal tumor","volume":"26","author":"Heinrich","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1007\/s00280-010-1526-3","article-title":"Molecular basis for primary and secondary tyrosine kinase inhibitor resistance in gastrointestinal stromal tumor","volume":"67","author":"Gounder","year":"2011","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1038\/sj.bjc.6601819","article-title":"Late resistance to imatinib therapy in a metastatic gastrointestinal stromal tumour is associated with a second KIT mutation","volume":"90","author":"Wakai","year":"2004","journal-title":"Br. J. Cancer"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1158\/1078-0432.CCR-11-2230","article-title":"KRAS and BRAF mutations predict primary resistance to imatinib in gastrointestinal stromal tumors","volume":"18","author":"Miranda","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"iv68","DOI":"10.1093\/annonc\/mdy095","article-title":"Gastrointestinal stromal tumours: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"29","author":"Casali","year":"2018","journal-title":"Ann. Oncol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1073\/pnas.1009199108","article-title":"Defects in succinate dehydrogenase in gastrointestinal stromal tumors lacking KIT and PDGFRA mutations","volume":"108","author":"Janeway","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1002\/gcc.20589","article-title":"Novel V600E BRAF mutations in imatinib-naive and imatinib-resistant gastrointestinal stromal tumors","volume":"47","author":"Agaram","year":"2008","journal-title":"Genes Chromosomes Cancer"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Belinsky, M.G., Rink, L., Cai, K.Q., Capuzzi, S.J., Hoang, Y., Chien, J., Godwin, A.K., and von Mehren, M. (2015). Somatic loss of function mutations in neurofibromin 1 and MYC associated factor X genes identified by exome-wide sequencing in a wild-type GIST case. BMC Cancer, 15.","DOI":"10.1186\/s12885-015-1872-y"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s00535-015-1132-6","article-title":"Gastrointestinal stromal tumors in Japanese patients with neurofibromatosis type I","volume":"51","author":"Nishida","year":"2016","journal-title":"J. Gastroenterol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.humpath.2017.01.005","article-title":"Clinicopathological and molecular features of a large cohort of gastrointestinal stromal tumors (GISTs) and review of the literature: BRAF mutations in KIT\/PDGFRA wild-type GISTs are rare events","volume":"62","author":"Huss","year":"2017","journal-title":"Hum. Pathol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1001\/jamaoncol.2016.0256","article-title":"Molecular subtypes of KIT\/PDGFRA wild-type gastrointestinal stromal tumors: A report from the National Institutes of Health Gastrointestinal Stromal Tumor Clinic","volume":"2","author":"Boikos","year":"2016","journal-title":"JAMA Oncol."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Vestergaard, L.K., Oliveira, D.N.P., Poulsen, T.S., H\u00f8gdall, C.K., and H\u00f8gdall, E.V. (2021). Oncomine Comprehensive Assay v3 vs. Oncomine Comprehensive Assay Plus. Cancers, 13.","DOI":"10.3390\/cancers13205230"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"e251270","DOI":"10.1136\/bcr-2022-251270","article-title":"Intestinal LMNA::NTRK1-fused spindle cell neoplasm with S100 and CD34 coexpression: A new case","volume":"15","author":"Rahim","year":"2022","journal-title":"BMJ Case Rep."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/01.pas.0000146010.92933.de","article-title":"Gastrointestinal stromal tumors of the stomach: A clinicopathologic, immunohistochemical, and molecular genetic study of 1765 cases with long-term follow-up","volume":"29","author":"Miettinen","year":"2005","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"40735","DOI":"10.18632\/oncotarget.9196","article-title":"Clinicopathological features and prognosis of colonic gastrointestinal stromal tumors: Evaluation of a pooled case series","volume":"7","author":"Feng","year":"2016","journal-title":"Oncotarget"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"3849850","DOI":"10.1155\/2019\/3849850","article-title":"Colonic gastrointestinal stromal tumor: A population-based analysis of incidence and survival","volume":"2019","author":"Liu","year":"2019","journal-title":"Gastroenterol. Res. Pract."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1038\/labinvest.3700122","article-title":"A great majority of GISTs with PDGFRA mutations represent gastric tumors of low or no malignant potential","volume":"84","author":"Lasota","year":"2004","journal-title":"Lab. Investig."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Rizzo, A., Pantaleo, M.A., Astolfi, A., Indio, V., and Nannini, M. (2021). The identity of PDGFRA D842V-mutant gastrointestinal stromal tumors (GIST). Cancers, 13.","DOI":"10.3390\/cancers13040705"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/modpathol.3880504","article-title":"c-kit mutations in gastrointestinal stromal tumors occur preferentially in the spindle rather than in the epithelioid cell variant","volume":"15","author":"Wardelmann","year":"2002","journal-title":"Mod. Pathol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S1525-1578(10)60510-7","article-title":"Association of platelet-derived growth factor receptor alpha mutations with gastric primary site and epithelioid or mixed cell morphology in gastrointestinal stromal tumors","volume":"6","author":"Wardelmann","year":"2004","journal-title":"J. Mol. Diagn."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/s12957-020-01961-1","article-title":"Extra-gastrointestinal stromal tumor arising in the lesser omentum with a platelet-derived growth factor receptor alpha (PDGFRA) mutation: A case report and literature review","volume":"18","author":"Kanamori","year":"2020","journal-title":"World J. Surg. Oncol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/modpathol.3880099","article-title":"Extragastrointestinal (soft tissue) stromal tumors: An analysis of 48 cases with emphasis on histologic predictors of outcome","volume":"13","author":"Reith","year":"2000","journal-title":"Mod. Pathol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/PAS.0000000000000807","article-title":"GIST manifesting as a retroperitoneal tumor: Clinicopathologic immunohistochemical, and molecular genetic study of 112 cases","volume":"41","author":"Miettinen","year":"2017","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1007\/s00423-005-0005-5","article-title":"Gastrointestinal stromal tumours: A regular origin in the muscularis propria, but an extremely diverse gross presentation. A review of 200 cases to critically re-evaluate the concept of so-called extra-gastrointestinal stromal tumours","volume":"391","author":"Agaimy","year":"2006","journal-title":"Langenbecks Arch. Surg."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1097\/PAS.0b013e3182986b88","article-title":"Gastrointestinal stromal tumors with KIT exon 9 mutations: Update on genotype-phenotype correlation and validation of a high-resolution melting assay for mutational testing","volume":"37","author":"Huss","year":"2013","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S0002-9440(10)64946-2","article-title":"KIT extracellular and kinase domain mutations in gastrointestinal stromal tumors","volume":"156","author":"Lux","year":"2000","journal-title":"Am. J. Pathol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S0002-9440(10)64623-8","article-title":"Mutations in exons 9 and 13 of KIT gene are rare events in gastrointestinal stromal tumors. A study of 200 cases","volume":"157","author":"Lasota","year":"2000","journal-title":"Am. J. Pathol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.5858\/2007-131-1393-IITMOM","article-title":"Imatinib in the management of multiple gastrointestinal stromal tumors associated with a germline KIT K642E mutation","volume":"131","author":"Graham","year":"2007","journal-title":"Arch. Pathol. Lab. Med."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1016\/j.ejca.2013.04.005","article-title":"Diagnosis, prognosis and treatment of patients with gastrointestinal stromal tumour (GIST) and germline mutation of KIT exon 13","volume":"49","author":"Bachet","year":"2013","journal-title":"Eur. J. Cancer"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"365","DOI":"10.4329\/wjr.v9.i9.365","article-title":"Imatinib response of gastrointestinal stromal tumor patients with germline mutation on KIT exon 13: A family report","volume":"9","author":"Engin","year":"2017","journal-title":"World J. Radiol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.medcli.2012.03.018","article-title":"[Familial gastrointestinal stroma tumor due to mutation in exon 13 (K642E) of the KIT gene]","volume":"139","year":"2012","journal-title":"Med. Clin."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"5913","DOI":"10.1158\/0008-5472.CAN-04-0085","article-title":"A missense mutation in KIT kinase domain 1 correlates with imatinib resistance in gastrointestinal stromal tumors","volume":"64","author":"Chen","year":"2004","journal-title":"Cancer Res."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/s41416-019-0389-6","article-title":"Complementary activity of tyrosine kinase inhibitors against secondary kit mutations in imatinib-resistant gastrointestinal stromal tumours","volume":"120","author":"Serrano","year":"2019","journal-title":"Br. J. Cancer"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"bcr2014208830","DOI":"10.1136\/bcr-2014-208830","article-title":"BRCA 1\/2 gene mutation and gastrointestinal stromal tumours: A potential association","volume":"2015","author":"Waisbren","year":"2015","journal-title":"BMJ Case Rep."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.21873\/anticanres.11466","article-title":"Familial gastrointestinal stromal tumor with germline KIT mutations accompanying hereditary breast and ovarian cancer syndrome","volume":"37","author":"Sekido","year":"2017","journal-title":"Anticancer Res."},{"key":"ref_55","first-page":"5221","article-title":"Lack of microsatellite instability in gastrointestinal stromal tumors","volume":"14","author":"Campanella","year":"2017","journal-title":"Oncol. Lett."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Park, J., Sul, H.J., and Kim, J.G. (2021). Rare occurrence of microsatellite instability in gastrointestinal stromal tumors. Medicina, 57.","DOI":"10.3390\/medicina57020174"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13053-016-0055-4","article-title":"Syndromic gastrointestinal stromal tumors","volume":"14","author":"Ricci","year":"2016","journal-title":"Hered. Cancer Clin. Pract."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1097\/PAS.0b013e3182260752","article-title":"Succinate dehydrogenase-deficient GISTs: A clinicopathologic, immunohistochemical, and molecular genetic study of 66 gastric GISTs with predilection to young age","volume":"35","author":"Miettinen","year":"2011","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"268ra177","DOI":"10.1126\/scitranslmed.3009961","article-title":"Recurrent epimutation of SDHC in gastrointestinal stromal tumors","volume":"6","author":"Killian","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1136\/jcp.2009.064550","article-title":"V600E BRAF mutations are alternative early molecular events in a subset of KIT\/PDGFRA wild-type gastrointestinal stromal tumours","volume":"62","author":"Agaimy","year":"2009","journal-title":"J. Clin. Pathol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1158\/1078-0432.CCR-16-0152","article-title":"Quadruple-Negative GIST Is a Sentinel for Unrecognized Neurofibromatosis Type 1 Syndrome","volume":"23","author":"Gasparotto","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/cam4.325","article-title":"Quadruple wild-type (WT) GIST: Defining the subset of GIST that lacks abnormalities of KIT, PDGFRA, SDH, or RAS signaling pathways","volume":"4","author":"Pantaleo","year":"2015","journal-title":"Cancer Med."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s41379-020-0623-z","article-title":"Mesenchymal tumors of the gastrointestinal tract with NTRK rearrangements: A clinicopathological, immunophenotypic, and molecular study of eight cases, emphasizing their distinction from gastrointestinal stromal tumor (GIST)","volume":"34","author":"Atiq","year":"2021","journal-title":"Mod. Pathol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"6105","DOI":"10.1158\/1078-0432.CCR-14-1677","article-title":"Tumor genotype is an independent prognostic factor in primary gastrointestinal stromal tumors of gastric origin: A european multicenter analysis based on ConticaGIST","volume":"20","author":"Wozniak","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1002\/ijc.11323","article-title":"Deletion of Trp-557 and Lys-558 in the juxtamembrane domain of the c-kit protooncogene is associated with metastatic behavior of gastrointestinal stromal tumors","volume":"106","author":"Wardelmann","year":"2003","journal-title":"Int. J. Cancer."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"6190","DOI":"10.1200\/JCO.2005.19.554","article-title":"Deletions affecting codons 557-558 of the c-KIT gene indicate a poor prognosis in patients with completely resected gastrointestinal stromal tumors: A study by the Spanish Group for Sarcoma Research (GEIS)","volume":"23","author":"Poveda","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s12032-013-0819-x","article-title":"Prognostic value of mutational characteristics in gastrointestinal stromal tumors: A single-center experience in 275 cases","volume":"31","author":"Wang","year":"2014","journal-title":"Med. Oncol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.3748\/wjg.14.1891","article-title":"KIT exon 11 codon 557\/558 deletion\/insertion mutations define a subset of gastrointestinal stromal tumors with malignant potential","volume":"14","author":"Dimitriadis","year":"2008","journal-title":"World J. Gastroenterol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1002\/cncr.23199","article-title":"Tumor mitotic rate, size, and location independently predict recurrence after resection of primary gastrointestinal stromal tumor (GIST)","volume":"112","author":"Dematteo","year":"2008","journal-title":"Cancer"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/00000478-200604000-00008","article-title":"Gastrointestinal stromal tumors of the jejunum and ileum: A clinicopathologic, immunohistochemical, and molecular genetic study of 906 cases before imatinib with long-term follow-up","volume":"30","author":"Miettinen","year":"2006","journal-title":"Am. J. Surg. Pathol."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/16\/16\/2907\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:40:35Z","timestamp":1760110835000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/16\/16\/2907"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,21]]},"references-count":70,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2024,8]]}},"alternative-id":["cancers16162907"],"URL":"https:\/\/doi.org\/10.3390\/cancers16162907","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,21]]}}}